NASDAQ:INMB | Operating Income | Inmune Bio, Inc.

Complete source-backed operating income history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$1.48M
2026-03-31-$5.81M
2025-12-31-$5.47M
2025-09-30-$7.43M
2025-06-30-$24.57M
2025-03-31-$9.91M
2024-12-31-$9.47M
2024-09-30-$12.29M
2024-06-30-$9.87M
2024-03-31-$11.02M
2023-12-31-$8.38M
2023-09-30-$8.53M
2023-06-30-$6.41M
2023-03-31-$6.42M
2022-12-31-$5.64M
2022-09-30-$7.44M
2022-06-30-$6.39M
2022-03-31-$6.48M
2021-12-31-$9.03M
2021-09-30-$9.02M
2021-06-30-$6.55M
2021-03-31-$4.55M
2020-12-31-$3.21M
2020-09-30-$4.82M
2020-06-30-$2.11M
2020-03-31-$2.09M
2019-12-31-$2.33M
2019-09-30-$3.08M
2019-06-30-$428,423.00
2019-03-31-$1.91M
2018-12-31-$1.88M
2018-09-30-$1.54M
2018-06-30-$6.17M
2018-03-31-$2.85M

Annual Operating Income

DateOperating Income
2025-12-31-$47.38M
2024-12-31-$42.64M
2023-12-31-$29.74M
2022-12-31-$25.95M
2021-12-31-$29.15M
2020-12-31-$12.23M
2019-12-31-$7.76M
2018-12-31-$12.44M
2017-12-31-$981,480.00